Iovance Biotherapeutics, Inc. (IOVA)
2.38
+0.03
(+1.28%)
USD |
NASDAQ |
Jan 14, 16:00
2.37
-0.01
(-0.42%)
After-Hours: 20:00
Iovance Biotherapeutics EPS Diluted (Quarterly): -0.2507 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| Intellia Therapeutics, Inc. | -0.9196 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| InfuSystem Holdings, Inc. | 0.1078 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -91.25M |
| Revenue (Quarterly) | 67.46M |
| Total Expenses (Quarterly) | 158.71M |
| Enterprise Value | 684.57M |
| Gross Profit Margin (Quarterly) | 29.61% |
| Profit Margin (Quarterly) | -135.3% |
| Earnings Yield | -50.50% |
| Normalized Earnings Yield | -50.09 |